Well, the market didn't like the announcement about PHASE 1 clinical trials being in Perth, NOT the States. I had heard the IND application paperwork went in late, however, the key to me is that SBP have FINALLY got Dr Robinson working with them; something they have been trying to achieve for several months. Reading between the lines, IMHO the breakthrough at Uni WA regarding the trigger of the immune system warrants further investigation and will give even greater profile to SBP worldwide. Wait for the various medical journals etc to comment then watch for the reaction. In summary, NOT the announcement I expected(explains the delays over last 3 weeks in releasing it) but still a hot stock as key entities interpret the BIG PICTURE. Timing: let's ask at the AGM-- should be a lively one!
SBP Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
